# Hemi-Y incision for nipple-sparing mastectomy with immediate implant reconstruction: 10-year outcomes from a single-center series

**Authors:** Chloe Jordan, Krzysztof Sosnowski, Rushabh Shah, Sanjeev Hariparsad, William M. Nabulyato, Parto Forouhi, Charles M. Malata

PMC · DOI: 10.1016/j.jpra.2026.01.050 · 2026-02-13

## TL;DR

A 10-year study shows the hemi-Y incision for nipple-sparing mastectomy with implant reconstruction has low complications and good long-term outcomes.

## Contribution

The study presents a 10-year follow-up of a specific incision technique for NSM with implant reconstruction, demonstrating its safety and effectiveness.

## Key findings

- The hemi-Y incision had a 15% early complication rate with no NAC necrosis or implant loss.
- A 10-year implant survival rate of 89% was observed with no local or NAC recurrences.
- The technique is suitable for small- to moderate-sized breasts and provides good scar concealment.

## Abstract

Nipple-sparing mastectomy (NSM) is increasingly performed for both risk-reducing and therapeutic indications, with oncological outcomes comparable to conventional mastectomy and improved aesthetic outcomes. Several incision patterns have been described, with no single approach universally preferred. The hemi-Y incision combines a limited peri‑areolar component (25% of the circumference) with an inferior radial extension from 6 o’clock, providing adequate exposure for mastectomy and implant placement in appropriately selected cases, while partially concealing the scar along the nipple–areola complex (NAC).

We performed a retrospective review of all patients undergoing hemi-Y NSM with immediate implant-based reconstruction at a tertiary center between November 2009 and December 2019. Data collected included demographics, comorbidities, oncological treatments, operative details, peri‑operative complications, and long-term outcomes.

Eleven patients (20 breasts) underwent hemi-Y NSM with immediate implant reconstruction. The cohort comprised predominantly risk-reducing procedures, with one case of ductal carcinoma in situ and no invasive carcinomas. Complete 10-year follow-up was available for nine patients (18 breasts); two patients (4 breasts) were lost to follow-up. Early complications occurred in 3 breasts (15%): one superficial wound dehiscence, one seroma, and one infection with wound breakdown. There were no cases of nipple-areola complex (NAC) or mastectomy skin-flap necrosis, or peri‑operative implant loss. Over 10 years, three patients (15%) required implant revision or exchange, giving a 10-year implant survival rate of 89% (16/18 breasts). No local or NAC recurrences were observed. One patient developed brain metastases at 10 years, while all remaining patients were alive and disease-free.

The hemi-Y incision provides adequate access for NSM and implant reconstruction with low complication rates and favorable scar concealment. Ten-year follow-up confirms durable reconstructive and oncological outcomes, supporting its role as a practical and reproducible option for patients undergoing NSM with implant reconstruction, predominantly in the risk-reducing and ductal carcinoma in situ (DCIS) setting. It should be considered in patients with small- to moderate-sized, non-ptotic breasts as a viable option for optimizing aesthetic outcomes following conservative mastectomy and implant-based reconstruction.

## Linked entities

- **Diseases:** ductal carcinoma in situ (MONDO:0005023)

## Full-text entities

- **Diseases:** Breast cancer (MESH:D001943), invasive (MESH:D009361), necrosis (MESH:D009336), metastases (MESH:D009362), infection (MESH:D007239), NSM (MESH:C000626393), contracture (MESH:D003286), dehiscence (MESH:D013529), seroma (MESH:D049291), DCIS (MESH:D002285), carcinomas (MESH:D009369)
- **Chemicals:** NAC (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12961206/full.md

---
Source: https://tomesphere.com/paper/PMC12961206